Table 5. Characteristics of the subjects... | American Society of Hematology

Table 5.

Characteristics of the subjects with a VTE event during the study, the relationship with a risk period, and the localization

Patient no.	Sex/age	Deficiency	Risk period	VTE localization
1	Male/17 y	Antithrombin	None	Femoro-popliteal thrombosis + PE
2	Female/1 y	Protein C*	None	Inferior vena cava thrombosis
3	Male/8 y	Protein C	CVL	Iliac-femoral thrombosis^†
4	Male/17 y	Protein C*	Trauma	Femoral thrombosis + PE
5	Female/15 y	Protein S	OCT	CSVT
6	Female/17 y	Protein S	OCT	Isolated PE

Patient no.	Sex/age	Deficiency	Risk period	VTE localization
1	Male/17 y	Antithrombin	None	Femoro-popliteal thrombosis + PE
2	Female/1 y	Protein C*	None	Inferior vena cava thrombosis
3	Male/8 y	Protein C	CVL	Iliac-femoral thrombosis^†
4	Male/17 y	Protein C*	Trauma	Femoral thrombosis + PE
5	Female/15 y	Protein S	OCT	CSVT
6	Female/17 y	Protein S	OCT	Isolated PE

CSVT, cerebral sinus venous thrombosis; PE, pulmonary embolism.

Plus Factor V Leiden mutation.

Following the placement of a central venous access during hospitalization for corrective surgery in Crouzon syndrome.